🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Bioventus Inc.

BVS Healthcare
$14.96 $-0.08 (-0.53%)
Market Cap: $1.26 B
Gurus Holding
5
Popularity Rank
#1684
% of Shares Held
3.72%
Net Activity (Q2 2026)
+$7.13 M

Guru Ownership Trend

Guru Analysis for Bioventus Inc. (BVS)

Bioventus Inc. (BVS), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $46.77 M.

Top institutional holders include Chuck Royce and Renaissance Technologies (RenTech).

Institutional sentiment is currently Bullish. This is evidenced by a $7.13 M net inflow during the quarter.

Recent activity highlights Steven Cohen who opened a new position. Conversely, Cliff Asness reduced exposure by 4.1%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q2 2026)

+$7.26 M
Total Buy Value
New Buys 2
Additions 2
-$131,348.18
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
4

FAQs for Bioventus Inc. (BVS)

Major holders include Chuck Royce ($17.31 M), Renaissance Technologies (RenTech) ($6.95 M), Cliff Asness ($3.08 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 3.13 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $7.13 M, with 4 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited BVS. The total reported sell value was $131,348.18.

Yes, 2 managers opened new positions in BVS, and 2 increased their existing holdings. The total reported buy value was $7.26 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.14% Add 18.9% 1,833,212 $17.31 M Q2 2026
0.01% Add 50.4% 736,000 $6.95 M Q2 2026
0.00% Reduce -4.1% 326,124 $3.08 M Q2 2026
0.00% New Buy 169,713 $1.6 M Q2 2026
0.00% New Buy 61,117 $576,944 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form